Martin Schneider

机构：Novartis (Switzerland), University Hospital Carl Gustav Carus · ORCID：0000-0001-8215-7359

发表论文 394 篇 · 总被引 10923 次 · h-index 47

代表论文

• Survival Outcome After Percutaneous Hepatic Perfusion with High-Dose Melphalan for Liver-Dominant Metastatic Uveal Melanoma: A 10-Year Single-Center Experience (2025 · Cancers · 被引 2)
• Digital Surveillance After Allogeneic Hematopoietic Stem Cell Transplantation Guides Therapeutic Interventions to Reduce Non‐Relapse Mortality (2026 · European Journal Of Haematology)
• Inclusion of a recovery period after pulse treatment in the primary human lymphocyte micronucleus assay covers potential cell cycle delays without loss of sensitivity (2026 · Mutagenesis)
• Data from Validation of Genetic Markers Associated with Survival in Colorectal Cancer Patients Treated with Oxaliplatin-Based Chemotherapy (2025)
• Supplementary Tables 1-4 from Validation of Genetic Markers Associated with Survival in Colorectal Cancer Patients Treated with Oxaliplatin-Based Chemotherapy (2025)
• Supplementary Table S2 from Pre-Surgery Inflammatory and Angiogenesis Biomarkers as Predictors of 12-Month Cancer-Related Distress: Results from the ColoCare Study (2025)